Status:

RECRUITING

The Effect of Dairy Intake on Body Weight and Composition and Metabolic Health in Adolescents and Seniors

Lead Sponsor:

University of Toronto

Conditions:

Dairy Consumption

Metabolic Health

Eligibility:

All Genders

14-75 years

Phase:

NA

Brief Summary

The goal of this study is to examine how regular dairy intake affects body weight, body composition, and metabolic health in overweight and prediabetic adolescents (ages 14-17) and older adults (ages ...

Eligibility Criteria

Inclusion

  • Age 14-17 years old (adolescents) or 60-75 years old (seniors)
  • BMI z-score \>+1SD, \<+2SD (adolescents) or BMI 25-30 kg/m2 (seniors)
  • Waist circumference \> 88 cm for women and \> 102 cm for men (seniors)
  • FBG 5.6-6.9 mmol/L (prediabetes)
  • Consumes ≤1 serving of dairy per day
  • Willing to maintain habitual diet, physical activity, and body weight throughout the study.
  • Willing to maintain current dietary supplement use throughout the study. On the first day, the participants agree not to take any dietary supplements until the completion of the study.
  • Willing to abstain from alcohol consumption for 24 hours prior to all test visits.
  • Willing to avoid vigorous physical activity for 24 hours prior to all test visits.
  • Understands the study procedures and is willing to provide informed consent by parent/guardian and assent by participant to participate in the study and authorization to release relevant protected health information to the study investigator.

Exclusion

  • Fasting BG ≥ 7mmol/L
  • Blood pressure systolic ≥ 130mmHg or diastolic ≥ 80mmHg (adolescents) or systolic ≥ 160 mmHg or diastolic pressure ≥ 100 mmHg
  • Smoking (tobacco and/or cannabis product use in the last 6 months)
  • Thyroid problems
  • History of CVDs, diabetes, liver or kidney disease, inflammatory bowel disease, celiac disease, short bowel syndrome, any malabsorption syndrome, pancreatitis, gallbladder, or biliary disease.
  • Presence of gastrointestinal disorder or surgeries within the past year.
  • Use of the prescription or non-prescription drugs, herbal or nutritional supplements known to affect the outcome of the study as per the investigator's judgment (including prebiotics and probiotics).
  • History of childhood obesity
  • Known to be pregnant, lactating, or not postmenopausal for at least a year and/or is taking hormonal treatments
  • Unwillingness or inability to comply with the experimental procedures
  • Known intolerance, sensitivity, or allergy to dairy, gluten, or any other study treatments.
  • Consumption of protein powders/supplements
  • Extreme dietary habits (e.g., Atkins diet, very high-protein diets, etc.)
  • Weight gain or loss of \>10 lbs. in the previous three months.
  • Excessive alcohol intake (more than 2 drinks per day or 9 per week)
  • Restrained eating, identified by a score of ≥11 on the Eating Habits Questionnaire

Key Trial Info

Start Date :

October 1 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2028

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT06879652

Start Date

October 1 2025

End Date

June 1 2028

Last Update

October 6 2025

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Department of Nutritional Sciences

Toronto, Ontario, Canada, M5S 1A8

2

Nutrition Intervention Center

Toronto, Canada, M5S 3H2